Community
TrustFinance is not a licensed financial advisor and is not affiliated with any financial institutions in your region. Please do your own research before investing.
Mexico
2015 (11 Years)
Last online: No recent activity
Be the first to rate and review this company.
Provided by TrustFinance
Be the first to rate and review this company.
TrustFinance is not a licensed financial advisor and is not affiliated with any financial institutions in your region. We encourage you to do your own research before making any investment decisions.
Warning
This company is currently Unproved.
Please be cautious of the potential risks!
License
A Grade License
Issued by globally renowned regulators, these licenses ensure the highest trader protection through strict compliance, fund segregation, insurance, and regular audits. Dispute resolution and adherence to AML/CTF standards further enhance security.
B Grade License
Granted by respected regional regulators, these licenses offer robust safety measures such as fund segregation, financial reporting, and compensation schemes. Though slightly less strict than Tier 1, they provide dependable regional protection.
C Grade License
Issued by regulators in emerging markets, these licenses offer basic protections such as minimum capital requirements and AML policies. Oversight is less stringent, so traders should exercise caution and verify safety measures.
D Grade License
From jurisdictions with minimal oversight, these licenses often lack key protections like fund segregation and insurance. While attractive for operational flexibility, they pose higher risks to traders.
TrustFinance is not a licensed financial advisor and is not affiliated with any financial institutions in your region. We encourage you to do your own research before making any investment decisions.
Get to know Anteris
Company Information
Get to know Anteris
Anteris Technologies Ltd is a public medical device company (ASX: AVR) focused on designing, developing, and commercializing innovative solutions for structural heart disease. The company's flagship product is the DurAVR™ 3D single-piece aortic valve replacement, which is engineered to be more durable and provide better hemodynamics compared to current-generation valves. Formerly known as Admedus, the company rebranded to Anteris to reflect its primary focus on this novel heart valve technology, with a mission to improve the lives of patients suffering from aortic stenosis.
Industry
Contact
-
-
-
-
Social
Company hasn't updated its information.
Reviews
Total 0
Filter
5 Star
4 Star
3 Star
2 Star
1 Star
Sort by
AI Review analysis
Let’s TrustFinance AI Summarize all the reviews for you.
Provided by TrustFinance AI Analysis
AI Review analysis
Let’s TrustFinance AI Summarize all the reviews for you.
Provided by TrustFinance AI Analysis